Market Research Logo

Medinol Ltd - Product Pipeline Analysis, 2018 Update

Summary

Medinol Ltd (Medinol) is a medical device company that researches, develops and manufactures cardiovascular intervention solutions. The company’s products include coronary stent system, bare metal stents, PTCA dilatation catheter, biliary metallic stent and self expanding peripheral stent. Its services comprise research, development, coating, quality control, regulatory affairs, clinical trials and studies, manufacturing, drug elution, traditional polymer coating services, marketing and sales. Medinol uses Flexx2 catheter technology, WiZeCell, eDES coating, and unique manufacturing technology to develop its products. Its stents are cut by water-jet laser from cobalt-chromium alloy panels. The company has operations in Tel Aviv and Jerusalem, Israel; and Parsippany, the US. Medinol is headquartered in Tel Aviv, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Medinol Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Medinol Ltd Company Overview
Medinol Ltd Company Snapshot
Medinol Ltd Pipeline Products and Ongoing Clinical Trials Overview
Medinol Ltd – Pipeline Analysis Overview
Medinol Ltd - Key Facts
Medinol Ltd - Major Products and Services
Medinol Ltd Pipeline Products by Development Stage
Medinol Ltd Ongoing Clinical Trials by Trial Status
Medinol Ltd Pipeline Products Overview
Elunir Elastomer Drug Eluting Stent
Elunir Elastomer Drug Eluting Stent Product Overview
Elunir Elastomer Drug Eluting Stent Clinical Trial
Elunir Elastomer Drug Eluting Stent - 38mm
Elunir Elastomer Drug Eluting Stent - 38mm Product Overview
Elunir Elastomer Drug Eluting Stent - 44mm
Elunir Elastomer Drug Eluting Stent - 44mm Product Overview
Medinol Ltd - Key Competitors
Medinol Ltd - Key Employees
Medinol Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Medinol Ltd, Recent Developments
Mar 19, 2018: Detroit Medical Center First to Use New Stent for Blocked Blood Vessels
Feb 06, 2018: DMC Heart Hospital is First in Michigan to Use the Narrowest Stent Width Available in the United States to Treat Coronary Disease
Jan 11, 2018: Cordis and Medinol Announce First U.S. Commercial Implants of Innovative EluNIR Drug-Eluting Stent
Nov 30, 2017: Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System
Oct 30, 2017: Cordis Showcases EluNIR Drug-Eluting Stent at TCT 2017
Oct 30, 2017: Cordis Showcases Medinol’s NIRxcell, a cobalt-chromium Bare Metal Coronary Stent at TCT 2017
Oct 26, 2017: Medinol Receives CE Mark for the EluNIR Ridaforolimus-Eluting Coronary Stent System, and announces first commercial implantations
Feb 16, 2017: Medinol Announces Appointment Of Harvey J. Berger, M.D., As Executive Chairman Of Medinol US
Dec 21, 2016: Medinol announces excellent clinical results for EluNIR, a novel Drug Eluting Stent
Nov 07, 2016: Medinol receives approval from the Japanese PMDA to begin clinical study on novel DES
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Medinol Ltd Pipeline Products and Ongoing Clinical Trials Overview
Medinol Ltd Pipeline Products by Equipment Type
Medinol Ltd Pipeline Products by Indication
Medinol Ltd Ongoing Clinical Trials by Trial Status
Medinol Ltd, Key Facts
Medinol Ltd, Major Products and Services
Medinol Ltd Number of Pipeline Products by Development Stage
Medinol Ltd Pipeline Products Summary by Development Stage
Medinol Ltd Ongoing Clinical Trials by Trial Status
Medinol Ltd Ongoing Clinical Trials Summary
Elunir Elastomer Drug Eluting Stent - Product Status
Elunir Elastomer Drug Eluting Stent - Product Description
Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) EUropean Angiography Study
Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis - PK Study
Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) in Coronary Stenosis Trial
Elunir Elastomer Drug Eluting Stent - Multi-center Study for Evaluating the Safety and Efficacy of the MedJ-01 Ridaforolimus Eluting Coronary Stent System (MedJ-01) In Coronary Stenosis Trial
Elunir Elastomer Drug Eluting Stent - 38mm - Product Status
Elunir Elastomer Drug Eluting Stent - 38mm - Product Description
Elunir Elastomer Drug Eluting Stent - 44mm - Product Status
Elunir Elastomer Drug Eluting Stent - 44mm - Product Description
Medinol Ltd, Key Employees
Medinol Ltd, Other Locations
Glossary
List of Figures
Medinol Ltd Pipeline Products by Equipment Type
Medinol Ltd Pipeline Products by Development Stage
Medinol Ltd Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report